Beirunning Appears at Zhejiang Ophthalmology Annual Meeting
Release time:
2020-07-22
Beirunning Appears at Zhejiang Ophthalmology Annual Meeting
News 11# July 15 - 17 , Zhejiang Institute of Integrated Traditional Chinese and Western Medicine Ophthalmology Annual Meeting Held in Huzhou, Zhejiang Province. Peak Pharmaceutical Company brought its products to the annual meeting and introduced Beirunning (Olopatadine Hydrochloride Eye Drops), the first domestic product that passed the consistency evaluation.
This annual meeting is co-sponsored by the Visual Function Professional Committee of Zhejiang Rehabilitation Medicine Association, the Ophthalmology Professional Committee of Zhejiang Integrative Medicine Association, and the Ophthalmology Professional Committee of Huzhou Medical Association. It is hosted by Zhejiang Hospital. There are mainly national continuing medical education class "New Progress in Diagnosis and Treatment of Visual Function Rehabilitation", and provincial continuing medical education class "Diagnosis and Treatment of Difficult Ophthalmology Diseases by Traditional Chinese and Western Medicine", the provincial continuing medical education class "integrated traditional Chinese and western medicine prevention and treatment of diabetic retinopathy seminar" and other content.
. At this annual meeting, the pharmaceutical company invited Zhang Huicheng, president of Hangzhou Qiushi Hospital and former president of the ophthalmology annual meeting of Zhejiang Integrated Traditional Chinese and Western Medicine Association, to introduce Jianfeng Pharmaceutical and Berunning products. He introduced in detail the causes of allergy, how to choose anti-eye allergy drugs, why to choose anti-allergy drugs with double-effect mechanism, and why to choose Berunning Olopatadine Hydrochloride Eye Drops of Zhejiang Jianfeng Pharmaceutical Co., Ltd. Beirunning is the first eye drops that have passed the consistency evaluation in China, and with its unique efficacy of antagonizing histamine H1- receptors, stabilizing mast cells and two-way anti-allergy has received widespread attention. Beirunning in the treatment of children with allergic conjunctivitis has good effect, fast curative effect, will not cause significant mast cell degranulation, so the use of more safe, and almost no adverse reactions to the eye tissue, is the current treatment of allergic conjunctivitis an ideal drug. Beirunning products have been unanimously recognized and praised by on-site ophthalmologists.
Participating in this annual meeting has improved the recognition of Berunning in Zhejiang ophthalmologists and laid a good foundation for the market promotion of Berunning in the later period. (Lin Xu)
More information
The company organized "charity one day donation"
On the morning of October 22, in the lobby on the first floor of Jianfeng Building, all cadres and employees of the group headquarters and subordinate enterprises working in Jianfeng Building participated in the 2021 "Charity Day Donation" activity to offer their love to Jinhua charity. In the next few days, the company's subordinate enterprises also organized "charity one-day donation" activities one after another.
2021
11-01
The company organizes new employee induction training
"Growth is more important than success. I hope everyone can become the backbone and pillars of the peak as soon as possible." On September 2, Yu Jianhong, general manager of the group company, put forward ardent hopes in the face of new employees. On the 2nd and 3rd, the group company organized induction training for new employees recruited in the past year. The group company chairman Jiang Xiaomeng, general manager Yu Jianhong and other leaders and relevant department heads gave lectures to them.
2021
09-13
Daye Peak: Typical Regional Industrial Green Development
On August 23, Huangshi Radio and Television Station broadcast the special program of "Strengthening Overall Planning and Promoting Energy Saving and Emission Reduction in Industrial Field". Daye Jianfeng Cement Company, as a typical enterprise with outstanding achievements in establishing green factories and energy saving and emission reduction in Huangshi area, appeared in the program.
2021
09-01
Yunnan Peak Helps Border Epidemic Prevention and Control
On August 22, Yunnan Peak Cement Company, through the Red Cross Society of Pu'er City and the Epidemic Prevention Headquarters of Pu'er City, donated vacuum insulation pots with a total value of 800000 yuan to the four border counties for the prevention and control of the new coronary pneumonia epidemic in the border area, and supported the prevention and control of the epidemic at the border with practical actions.
2021
09-01
Group Party Committee to Learn "July 1" Important Speech
On August 13, the party committee of the group company held a special meeting to collectively study General Secretary Xi Jinping's important speech at the celebration meeting of the 100 anniversary of the founding of the Communist Party of China, convey the requirements of the party committee at a higher level, and make arrangements for organizing party members of the company to study the "July 1" speech.
2021
08-23
Spike Ranked 2020 China's Top 100 Cement Clinker Production Capacity
Recently, the company received the "2020 China Cement Clinker Production Capacity Top 100" plaque issued by China Cement Network. The ranking of China's top 100 cement clinker production capacity is organized and evaluated by China Cement Network, an authoritative information platform for the domestic cement industry. It is released according to the actual clinker production capacity of each cement enterprise at the end of last year. The company has been ranked in the top 100 list for many consecutive years.
2021
08-23